| Literature DB >> 33244341 |
Yahaya Muhammad1, Yamuna Kani Aminu2, Abdurrahman Elfulaty Ahmad3, Sani Iliya4, Nuruddeen Muhd5, Mohammed Yahaya1, Aminu Sale Mustapha6, Abdulkhabir Tahiru1, Sulaiman Saeed Abdulkadir7, Jamila Suleiman Ibrahim8, Abdulmalik Binji Ahmad9, Idris Yahaya Muhammad9, Zaharaddeen Shehu10, Abdulrahman Yakubu6, Bashir Kabir Muhd11, Armaya'u Ahmed12, Umar Abubakar Faruk13.
Abstract
INTRODUCTION: the most recently discovered severe acute respiratory syndrome Coronavirus 2 (SARS-COV-2) that causes COVID-19, subjected the entire world in turmoil health-wise and economically. With higher burden of malaria in Nigeria and other sub-Saharan African countries coupled with fragile healthcare system and delivery, these may pose a threat in the diagnosis and management of COVID-19 patients co-infected with malaria. Free radicals have been implicated in the progression and pathogenesis of malaria and COVID-19 through Fenton's reaction and cytokine storm respectively.Entities:
Keywords: COVID-19; malaria; oxidative stress
Mesh:
Substances:
Year: 2020 PMID: 33244341 PMCID: PMC7680236 DOI: 10.11604/pamj.2020.37.78.25100
Source DB: PubMed Journal: Pan Afr Med J
Figure 1polymerase chain reaction identifier cycling: ORF1ab, N-genes & IC
Figure 2comparison of 8-iso-PGF2α. Scatter plot showing significant increase in 8-iso-PGF2α in both co-infected and COVID-19 groups compared to the control group by one-way ANOVA and Tukey´s multiple comparison post-hoc analysis
comparison of 8-iso-PGF2α and Alphatocopherol levels in COVID-19 patient only, co-infected with malaria and control group
| Parameters | COVID (n=20) | Co-infected (n=34) | Controls (n=20) | p-value* | Level of significance |
|---|---|---|---|---|---|
| 8-iso-PGF2α (pg/mL) | 93.5±8.1 | 131.6±9.5 | 58.2±6.3 | <0.0001 | HS |
| Alphatocopherol | 3.86±0.82 | 2.40±0.51 | 9.82±1.09 | <0.0001 | HS |
HS= highly significant; Co-infected=COVID-19 patients co-infected with malaria; n=number of subjects; *determined by one-way ANOVA
8-iso-PGF2α levels in COVID-19 patients co-infected with malaria in relation to malaria parasite density values
| MPD values | 8-iso-PGF2α (pg/mL) |
|---|---|
| <6,000 | 124.8±3.6 |
| 6000-15,000 | 124.4±10.0 |
| 16,000-30,000 | 133.1±5.3 |
| >30,000 | 142.7±4.9 |
MPD; Malaria parasite density; 8-iso-PGF2α; 8-isoprostaglandin F2 alpha
Figure 3distribution of COVID-19-malaria co-infected patients based on malaria parasite density values
Pearson correlation test for relationship between serum levels of 8-isoPGF2 and alphatocopherol among COVID-19 co-infected with malaria
| 8-isoPGF2alpha | Alphatocopherol | |
|---|---|---|
| Pearson Correlation | 1 | -.551** |
| Sig. (2 tailed) | 0.001 | |
| N | 34 | 34 |
| Pearson Correlation | -.551** | |
| Sig. (2 tailed) | 0.001 | |
| N | 34 |
Correlation is significant at the 0.001 level (2-tailed); N: number of subjects